Ticker
SCYXCompany Name
SCYNEXIS INCSector
HealthcareIndustry
Drug Manufacturers - Specialty & GenericExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 60.69M | $ 11.26M | 18.56% |
3/31/2025 | $ 67.92M | $ 7.49M | 11.02% |
12/31/2024 | $ 90.64M | $ 16.59M | 18.31% |
9/30/2024 | $ 99.04M | $ 29.27M | 29.56% |
6/30/2024 | $ 107.81M | $ 26.54M | 24.62% |
3/31/2024 | $ 118.25M | $ 36.02M | 30.46% |
12/31/2023 | $ 128.41M | $ 34.59M | 26.94% |
9/30/2023 | $ 148.55M | $ 44.62M | 30.03% |
6/30/2023 | $ 154.86M | $ 58.5M | 37.78% |
3/31/2023 | $ 70.3M | $ 27.13M | 38.6% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for SCYNEXIS INC is calculated as follows: CashnEq [ $ 29.77M ] / Assets [ $ 36.75M ]
(=) Cash to Assets [ 80.99% ]
Minimum
Mar 31, 2025
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.89% |
average | 9.83% |
median | 6.44% |
std | 9.6% |